Outlook Therapeutics, Inc. (NASDAQ:OTLK)’s stock price gapped up prior to trading on Thursday . The stock had previously closed at $0.57, but opened at $0.59. Outlook Therapeutics shares last traded at $0.88, with a volume of 6,000,159 shares changing hands. Several equities analysts have weighed in on OTLK shares. Zacks Investment Research Outlook Therapeutics, Inc. (NASDAQ:OTLK)’s share price rose 12.2% during trading on Tuesday . The company traded as high as $0.60 and last traded at $0.59, approximately 2,183,280 shares traded hands during mid-day trading. An increase of 34% from the average daily volume of 1,624,140 shares. The stock had previously closed at $0.53. OTLK has Harrow Health (NASDAQ:HROW) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Wednesday, Zacks.com reports. According to Zacks, “Harrow Health Inc. owns a portfolio of healthcare businesses, including an ophthalmology pharmaceutical compounding business, ImprimisRx. The company Stock split history for Oncobiologics since 2020. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Outlook Therapeutics (Nasdaq:OTLK) issued its quarterly earnings data on Thursday. The company reported ($0.12) EPS for the quarter, beating the consensus estimate of ($0.31) by $0.19, Fidelity Earnings reports.
Outlook Therapeutics, Inc. (NASDAQ:OTLK)’s share price traded down 49.6% on Monday . The company traded as low as $0.52 and last traded at $0.58, 5,896,367 shares changed hands during mid-day trading. An increase of 263% from the average session volume of 1,626,284 shares. The stock had previously closed at $1.15. Several equities research Outlook Therapeutics, Inc. (NASDAQ:OTLK)’s share price dropped 8.9% during trading on Thursday . The company traded as low as $1.23 and last traded at $1.23, approximately 523,340 shares were traded during mid-day trading. A decline of 68% from the average daily volume of 1,657,024 shares. The stock had previously closed at $1.35. OTLK has OTLK Stock News and Research Articles - Outlook Therapeutics : latest news, headlines and research articles. Home Homepage Membership Levels Membership Data Coverage Complete Stock List Founder's Message The book Value Investing Forum Podcast Free Trial Screeners Value Screens 28/09/2017 · Find the latest Roku, Inc. (ROKU) stock quote, history, news and other vital information to help you with your stock trading and investing. 09/01/2020 · Outlook Therapeutics, Inc. (NASDAQ:OTLK) shares gapped up before the market opened on Thursday . The stock had previously closed at $0.81, but opened at $0.89. Outlook Therapeutics shares last traded at $0.91, with a volume of 3,442,154 shares. OTLK … The Wall Street of Stock Trading and Investing Financial Community Site for Traders and Investors. Free stock quotes, news, research, message postings, stock picks, chat rooms, and financial content. The Wall Street of Stock Trading and Investing Financial Community Site for Traders and Investors. Free stock quotes, news, research, message postings, stock picks, chat rooms, and financial content.
Trading Signals for Outlook Therapeutics Inc with Buy, Sell, Hold recommendations, technical analysis, and trading strategy.
Trading Signals for Outlook Therapeutics Inc with Buy, Sell, Hold recommendations, technical analysis, and trading strategy.